Physicochemical Properties
| Molecular Formula | C26H39NO2 |
| Molecular Weight | 397.593367815018 |
| Exact Mass | 397.298 |
| CAS # | 883715-23-9 |
| PubChem CID | 73353637 |
| Appearance | Colorless to light yellow liquid |
| Density | 0.961±0.06 g/cm3 |
| Boiling Point | 562.1±50.0 °C at 760 mmHg |
| Flash Point | 293.8±30.1 °C |
| Vapour Pressure | 0.0±1.5 mmHg at 25°C |
| Index of Refraction | 1.516 |
| LogP | 7.44 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 16 |
| Heavy Atom Count | 29 |
| Complexity | 481 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | C(C1C=CC=C(OC)C=1)NC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC |
| InChi Key | XKHCEDYSKNATME-YSTUJMKBSA-N |
| InChi Code | InChI=1S/C26H39NO2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21-26(28)27-23-24-19-18-20-25(22-24)29-2/h4-5,7-8,10-11,18-20,22H,3,6,9,12-17,21,23H2,1-2H3,(H,27,28)/b5-4-,8-7-,11-10- |
| Chemical Name | (9Z,12Z,15Z)-N-[(3-methoxyphenyl)methyl]octadeca-9,12,15-trienamide |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture and light. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
[1]. N-(3-methoxybenzyl)-(9Z,12Z,15Z)-octadecatrienamide promotes bone formation via the canonical Wnt/β-catenin signaling . pathwayPhytother Res. 2019 Apr;33(4):1074-1083. |
| Additional Infomation |
N-(3-Methoxybenzyl)-(9Z,12Z,15Z)-octadecatrienamide has been reported in Lepidium meyenii with data available. See also: Lepidium meyenii root (part of). |
Solubility Data
| Solubility (In Vitro) | DMSO : ~100 mg/mL (~251.52 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (6.29 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (6.29 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (6.29 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.5152 mL | 12.5758 mL | 25.1515 mL | |
| 5 mM | 0.5030 mL | 2.5152 mL | 5.0303 mL | |
| 10 mM | 0.2515 mL | 1.2576 mL | 2.5152 mL |